. 2019 Sep 5;58(42):15000–15004. doi: 10.1002/anie.201909536
© 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Figure 1.
Potential prodan‐derived pyrazolopyrimidine kinase inhibitors.